Michael Bronze to Anti-Bacterial Agents
                            
                            
                                This is a "connection" page, showing publications Michael Bronze has written about Anti-Bacterial Agents.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.820
         
        
        
     
 
    
        
        - 
            Gatifloxacin-associated hypoglycemia. J Okla State Med Assoc. 2007 Nov; 100(11):425-8.
            
            
                Score: 0.204
             
- 
            Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanide. J Okla State Med Assoc. 2007 Jul; 100(7):267-72.
            
            
                Score: 0.199
             
- 
            Infection caused by Rahnella aquatilis. Am J Med Sci. 2010 Jun; 339(6):577-9.
            
            
                Score: 0.061
             
- 
            Part X. Tetracycline and glycylcycline antimicrobials. J Okla State Med Assoc. 2007 Jun; 100(6):241-7.
            
            
                Score: 0.050
             
- 
            Part IX. Quinolone antimicrobials. J Okla State Med Assoc. 2007 May; 100(5):149-56.
            
            
                Score: 0.049
             
- 
            Antimicrobial symposium. Part VI. Aminoglycosides and polymyxins. J Okla State Med Assoc. 2007 Feb; 100(2):60-4.
            
            
                Score: 0.048
             
- 
            Part V. Other beta-lactam antimicrobials. J Okla State Med Assoc. 2007 Jan; 100(1):23-5.
            
            
                Score: 0.048
             
- 
            Part II. Introduction to the beta-lactam antibiotics. J Okla State Med Assoc. 2006 Oct; 99(10):516-20.
            
            
                Score: 0.047
             
- 
            Current therapy and the development of therapeutic options for the treatment of diseases due to bacterial agents of potential biowarfare and bioterrorism. Curr Opin Investig Drugs. 2004 Feb; 5(2):135-40.
            
            
                Score: 0.039
             
- 
            Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents. Drug Discov Today. 2003 Oct 01; 8(19):881-8.
            
            
                Score: 0.038
             
- 
            The reemergence of serious group A streptococcal infections and acute rheumatic fever. Am J Med Sci. 1996 Jan; 311(1):41-54.
            
            
                Score: 0.022
             
- 
            Antimicrobial symposium. Part VIII. Glycopeptides, oxazolidinones, and lipopeptides. J Okla State Med Assoc. 2007 Apr; 100(4):105-11.
            
            
                Score: 0.012